Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/3/26 16:21 | 2/27/26 | JNJ | Health | Drug | Pharmaceutical Preparations | Decker Robert J | NJ | O | VP Corpo | 1 | S.d | -1,010 | 247.87 | 0 | -4 | 24 | D | |||||||||||||||
2/23/26 17:20 | 2/20/26 | JNJ | Health | Drug | Pharmaceutical Preparations | Schmid Timothy | NJ | O | EVP,WW C | 2 | S.d | -5,852 | 244.40 | 0 | -24 | 28 | D | |||||||||||||||
2/18/26 21:12 | 2/13/26 | JNJ | Health | Drug | Pharmaceutical Preparations | Swanson James D. | NJ | O | EVP,CIO | 1 | S.dm | -15,110 | 243.39 | 0 | -62 | 26 | D | |||||||||||||||
2/18/26 21:12 | 2/17/26 | JNJ | Health | Drug | Pharmaceutical Preparations | Wolk Joseph J | NJ | O | EVP,CFO | 1 | S.d | -21,768 | 242.80 | 0 | -90 | 85 | D | |||||||||||||||
2/18/26 21:12 | 2/17/26 | JNJ | Health | Drug | Pharmaceutical Preparations | Reed John C | NJ | O | EVP,Inno | 1 | S.d | -13,105 | 243.00 | 0 | -54 | 11 | D | |||||||||||||||
2/18/26 21:11 | 2/17/26 | JNJ | Health | Drug | Pharmaceutical Preparations | Broadhurst Vanessa | NJ | O | EVP,Glob | 1 | S.d | -1,508 | 243.39 | 0 | -6 | 23 | D | |||||||||||||||
1/28/26 18:07 | 1/26/26 | JNJ | Health | Drug | Pharmaceutical Preparations | Duato Joaquin | NJ | DO | CEO,CB | 1 | S | -22,123 | 221.23 | 0 | -100 | 308 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |